Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 24 hours
    • Any time
    • Past hour
    • Past 7 days
    • Past 30 days
  • Most recent
    • Best match

News

ascopubs.org15h
First-line nivolumab (anti-PD-1; BMS-936558, ONO-4538) monotherapy in advanced NSCLC: Safety, efficacy, and correlation of outcomes with PD-L1 status.
Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Lets revoke parole program
Tariffs back on for now
Feds probe impersonator
Jailed for selling daughter
Canada wildfires spread
Deaf Americans sue Trump
DOJ cuts ABA judicial vetting
SCOTUS narrows NEPA
National Spelling Bee winner
Paul Ingrassia to lead OSC
Brand pleads not guilty
Ex-NYPD commissioner dies
Garcia eyes Oversight role
On US-China trade talks
Sale reaches 2,500 strikeouts
Signs AI deal with Amazon
US govt. employee charged
DOJ moves to dismiss case
Ex-banker sentenced
To run for US Senate
SEC dismisses Binance suit
Powell meets with Trump
Foreign student ban halted
To challenge Graham
Saharan dust heads for FL
MLB announces investment
US scholar leaves Thailand
Beef stew recall
Unveils new supercomputer
US inflation gauge cools
ICE leadership overhaul
Prosecution rests its case
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy